You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 8, August 2003 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (11)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Quality of Life
 •Behavioral Neurology
 •Randomized Controlled Trial
 •Prognosis/ Outcomes
 •Pediatric Neurology
 •Alert me on articles by topic

Reliability of 4 Outcome Measures in Pediatric Spinal Muscular Atrophy

Susan T. Iannaccone, MD; Linda S. Hynan, PhD; and the American Spinal Muscular Atrophy Randomized Trials (AmSMART) Group

Arch Neurol. 2003;60:1130-1136.

Background  Spinal muscular atrophy is a common neurologic disorder of infants and children with a high mortality rate. Clinical trials have not been attempted in this population until recently.

Objective  To demonstrate that 4 outcome measures are reliable for use in clinical trials in patients with spinal muscular atrophy.

Design, Setting, Patients  Thirty-eight children with spinal muscular atrophy who fulfilled inclusion and exclusion criteria were enrolled at 5 pediatric centers for a reliability study. Paired samples statistics were performed comparing results of the qualifying variance visit with a fourth visit.

Main Outcome Measures  Quantitative muscle testing and the Gross Motor Function Measure.

Results  Thirty-four patients and 7 evaluators completed the study. Thirteen patients were aged 2 through 4 years and 21 were 5 through 17 years. The Gross Motor Function Measure was completed by 34 subjects. Six variables for pulmonary function tests were measured in 20 subjects. Quantitative muscle testing was performed on 21 subjects in 8 muscle groups. Thirty-three subjects completed the PedsQL Neuromuscular Module for Parents. The intraclass correlation coefficient and Bradley-Blackwood procedures indicated a very high level of agreement between measures.

Conclusion  The Gross Motor Function Measure, pulmonary function tests, quantitative muscle testing, and quality of life are reliable outcome measures for clinical trials in pediatric spinal muscular atrophy.


From the Department of Neurology, Texas Scottish Rite Hospital for Children, Dallas (Dr Iannaccone); and Academic Computing Services, University of Texas Southwestern Medical Center at Dallas (Dr Hynan). A complete list of the members of the AmSMART Group appears in the box.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Modern Management of Spinal Muscular Atrophy
Iannaccone
J Child Neurol 2007;22:974-978.
ABSTRACT  

Consensus Statement for Standard of Care in Spinal Muscular Atrophy
Wang et al.
J Child Neurol 2007;22:1027-1049.
ABSTRACT  

Outcome of noninvasive ventilation in children with neuromuscular disease
Young et al.
Neurology 2007;68:198-201.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.